Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
AbbVie
Silvio Danese; Séverine Vermeire; Wen Zhou; Aileen L Pangan; Jesse Siffledeen; Susan Greenbloom; Xavier Hébuterne; Geert D'Haens; Hiroshi Nakase; Julian Panés; Peter D R Higgins; Pascal Juillerat; James O Lindsay; Edward V Loftus; William J Sandborn; Walter Reinisch; Min-Hu Chen; Yuri Sanchez Gonzalez; Bidan Huang; Wangang Xie; John Liu; Michael A Weinreich; Remo Panaccione